Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital DischargeMattia Bellan, Mario Pirisi|JAMA Network Open|2021Cited by 493
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trialFrances Humby, Raquel Celis, Hasan Rizvi et al.|The Lancet|2021Cited by 315